Letter to the Editor
Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab
Experiencia inicial con aflibercept intravítreo en la degeneración macular asociada a la edad exudativa refractaria al tratamiento con ranibizumab o bevacizumab
R.E. Cervera
, V. Castro, J. Montero, C. Torralba, A. Gracia
Corresponding author
Servicio de Oftalmología, Hospital General Universitario, Valencia, Spain
Read
967
Timeswas read the article
231
Total PDF
736
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2018 2 | 5 | 2 | 7 |
| 2018 1 | 1 | 1 | 2 |
| 2017 12 | 1 | 0 | 1 |
| 2017 11 | 8 | 0 | 8 |
| 2017 10 | 7 | 1 | 8 |
| 2017 9 | 2 | 2 | 4 |
| 2017 8 | 7 | 5 | 12 |
| 2017 7 | 9 | 2 | 11 |
| 2017 6 | 14 | 6 | 20 |
| 2017 5 | 16 | 6 | 22 |
| 2017 4 | 17 | 28 | 45 |
| 2017 3 | 25 | 12 | 37 |
| 2017 2 | 25 | 0 | 25 |
| 2017 1 | 10 | 0 | 10 |
| 2016 12 | 28 | 5 | 33 |
| 2016 11 | 14 | 6 | 20 |
| 2016 10 | 24 | 16 | 40 |
| 2016 9 | 17 | 2 | 19 |
| 2016 8 | 17 | 4 | 21 |
| 2016 7 | 14 | 2 | 16 |
| 2016 6 | 15 | 3 | 18 |
| 2016 5 | 13 | 3 | 16 |
| 2016 4 | 10 | 2 | 12 |
| 2016 3 | 22 | 1 | 23 |
| 2016 2 | 15 | 8 | 23 |
| 2016 1 | 17 | 5 | 22 |
| 2015 12 | 15 | 9 | 24 |
| 2015 11 | 12 | 4 | 16 |
| 2015 10 | 16 | 5 | 21 |
| 2015 9 | 12 | 4 | 16 |
| 2015 8 | 7 | 3 | 10 |
| 2015 7 | 11 | 6 | 17 |
| 2015 6 | 9 | 1 | 10 |
| 2015 5 | 14 | 6 | 20 |
| 2015 4 | 18 | 12 | 30 |
| 2015 3 | 21 | 4 | 25 |
| 2015 2 | 10 | 3 | 13 |
| 2015 1 | 26 | 3 | 29 |
| 2014 12 | 24 | 7 | 31 |
| 2014 11 | 21 | 3 | 24 |
| 2014 10 | 30 | 8 | 38 |
| 2014 9 | 46 | 6 | 52 |
| 2014 8 | 46 | 12 | 58 |
| 2014 7 | 45 | 13 | 58 |
Show all
